Skip to content
Catalyst

Lepidium meyeniiFinding

Lepidium meyenii has no detected effect on serious adverse event incidence

no difference foundModerate evidenceFinding

01 · The sentence it was drawn from

“No serious adverse effect was reported in the groups treated with a placebo, red maca, or black maca at LA and at HA.”
Quoted verbatim from Acceptability, Safety, and Efficacy of Oral Administration of Extracts of Black or Red Maca (Lepidium meyenii) in Adult Human Subjects: A Randomized, Double-Blind, Placebo-Controlled Study.
This finding among the 11 findings on its endpoint

Lepidium meyenii

Serious adverse event incidence

no difference found

Who
Healthy adults aged 18-65, men and women, living at low altitude (Lima) and high altitude (Cerro de Pasco), Peru; red maca arm and black maca arm alongside a maltodextrin placebo arm
Dose studied
3 g/day in a sachet, 12 weeks

Moderate evidencePMID 27548190 · 2016

02 · The study

Study
RCT
Duration
3 months

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

03 · The paper

Pharmaceuticals (Basel, Switzerland)
What else it reported2 findings · 0 compounds · 2 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M701Y4AF1KYTN83S1A25YBDW